Drug Access Debate

Scott discusses the complexities of drug access for patients, emphasizing the ethical concerns surrounding placebo trials in oncology. He argues for the growing acceptance of real-world data as a valid form of evidence, suggesting that advancements in data collection and analysis could eventually rival traditional clinical trial methods. The conversation highlights the ongoing debate within the medical community regarding the balance between rigorous testing and patient access to potentially life-saving treatments.